Stock Analiz

Quantum Cyber N.V. QUCY

Biotechnology: Pharmaceutical Preparations · IPO 2021 · data as of November 13, 2026

$0.63Market cap $55M
Open the interactive analysis →

Quantum Cyber N.V. (QUCY) is a healthcare company listed in the US with a market value of about $55M. In fiscal year 2025 it had revenue of $537080 and net income of -$16M, a net margin of -3018.3%.

Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is future growth (1/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of 2% a year, a 5-year average ROIC of -301%.

About Quantum Cyber

Quantum Cyber is listed in the US and classified in biotechnology: pharmaceutical preparations, IPO year 2021. Revenue went from $281393 in 2019 to $537080 in 2025, growth of about 11.4% a year. It was profitable in 0 of the last 7 years in our data. It spends 913% of revenue on research and development.

Score: 0.4 / 5

Value0/5
Future growth1/5
Track record0/5
Financial health1/5
Shareholder returns0/5

Checks passed

  • Strong R&D investment or growth above 20%
  • More cash than debt, or low debt to equity

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S102.8
P/B3.4
EV/EBITDA—
PEG—
Dividend yield0.00%
FCF yield-29.0%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-39.9%
Revenue growth (5 yrs, per year)1.7%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-3076.2%
ROIC (5-yr avg.)-301.4%
Profitable years (of last 10)0
Years paying a dividend—

Financials, last 7 years

Fiscal year2025202420232022202120202019
Revenue$537080$893991$895479$529877$577348$493565$281393
Net income-$16M-$22M-$26M-$26M-$12M-$586895-$957055
Free cash flow-$11M-$17M-$23M-$15M-$3M-$478422—
EPS (diluted)$-0.19$-0.25$-0.30$-0.30$-0.13$-0.01$-0.01
Net margin-3018.3%-2416.0%-2941.9%-4979.9%-2024.8%-118.9%-340.1%
ROIC-432.6%-180.2%-627.8%-147.4%-119.3%——

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 1 analysts is $9.00, 1322% above the current price; targets range from $9.00 to $9.00; the consensus rating is “none”; expected EPS is $-0.49 for the fiscal year ending December 31, 2026.

Frequently asked questions

Does Quantum Cyber pay a dividend?

Not currently.

Is Quantum Cyber a good stock to buy?

We do not give buy or sell advice. Quantum Cyber scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.